Skip to main content
Have a personal or library account? Click to login
Urine Ochratoxin A and Sphinganine/Sphingosine Ratio in Residents of the Endemic Nephropathy Area in Croatia Cover

Urine Ochratoxin A and Sphinganine/Sphingosine Ratio in Residents of the Endemic Nephropathy Area in Croatia

Open Access
|Jan 2010

References

  1. Krogh P. Mycotoxic porcine nephropathy: a possible model for Balkan endemic nephropathy. In: Puchlev E, editor. Endemic Nephropathy. Proceedings of the 2International Symposium on Endemic Nephropathy; 9-11 Nov 1972; Sofia, Boulgaria. Sofia: Publishing House of Bulgarian Academy of Sciences; 1974. p. 266-70.
  2. Čeović S, Pleština R, Miletić-Medved M, Stavljenić A, Mitar J, Vukelić M. Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia. In: Castegnaro M, Pleština R, Dirheimer G, Chernozemsky IN, Bartsch H, editors. Mycotoxins, endemic nephropathy and urinary tract tumours. Lyon: IARC; 1991. p. 5-10.
  3. Miletić-Medved M, Domijan A-M, Peraica M. Recent data on endemic nephropathy and related urothelial tumors in Croatia.2005;117:604-9.
  4. International Programme on Chemical Safety (IPCS). Safety evaluation of certain mycotoxins in food. WHO Food Additives Series, Vol. 47. Geneva: WHO/FAO; 2001.
  5. International Agency for Research on Cancer (IARC). Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56. Lyon: IARC/WHO; 1993.
  6. Pavlović M, Pleština R, Krogh P. Ochratoxin A contamination of foodstuffs in an area with Balkan (endemic) nephropathy.1979;87:243-6.
  7. Jurjević Ž, Solfrizzo M, Cvjetković B, Avantaggiato G, Visconti A. Ochratoxin A and fumonisins (Band B) in maize form Balkan nephropathy endemic and non endemic areas of Croatia.1999;15:67-80.
  8. Puntarić D, Bošnir J, Šmit Z, Škes I, Baklaić Z. Ochratoxin A in corn and wheat: geographical association with endemic nephropathy.2001;42:175-80.
  9. Radić B, Fuchs R, Peraica M, Lucić A. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia.1997;91:105-9.
  10. Peraica M, Domijan A-M, Fuchs R, Lucić A, Radić, B. The occurrence of ochratoxin A in blood in general population of Croatia.1999;110:105-12.
  11. Domijan A-M, Peraica M, Jurjević Ž, Ivić D, Cvjetković B. Fumonisin B, fumonisin B, zearalenone and ochratoxin A contamination of maize in Croatia.2005;22:677-80.
  12. International Agency for Research on Cancer (IARC). Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 82. Lyon: IARC; 2002.
  13. Ribar S, Mesarić M, Bauman M. High-performance liquid chromatographic determination of sphinganine and sphingosine in serum and urine of subjects from an endemic nephropathy area in Croatia.2001;754:511-9.
  14. Pascale M, Visconti A. Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high-performance liquid chromatography.2000;152:91-5.
  15. Solfrizzo M, Avantagiato G, Visconti A. Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure.1997;692:87-93.
  16. Fazekas B, Tar A, Kovacs M. Ochratoxin A content of urine samples of healthy humans in Hungary.2005;53:35-44.
  17. Pena A, Seifrtova M, Lino C, Silveira I, Solich P. Estimation of ochratoxin A in Portuguese population: New data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection.2006;44:1449-54.
  18. Meteorological and Hydrological Service of Croatia [displayed 11 May 2009]. Available at
  19. Solfrizzo M, Chulze SN, Mallmann C, Visconti A, De Girolamo A, Rojo F, Torres A. Comparison of urinary sphingolipids in human populations with high and low maize consumption as a possible biomarker of fumonisin dietary exposure.2004;21:1090-5.
  20. Westhuizen van der L, Brown NL, Marasas WFO, Swanevelder S, Shephard GS. Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa.1999;37:1153-8.
  21. Qiu M, Liu X. Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B.2001;18:263-9.
  22. Creppy EE, Chiarappa P, Baudrimont I, Borracci P, Moukha S, Carratù MR. Synergistic effects of fumonisin Band ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?2004;201:115-23.
  23. Šegvić Klarić M, Pepeljnjak S, Domijan A-M, Petrik J. Lipid peroxidation and glutathione levels in porcine kidney PK15 cells after individual and combined treatment with fumonisin B, beauvericin and ochratoxin A.2007;100:157-64.
  24. Domijan A-M, Želježić D, Kopjar N, Peraica M. Standard and Fpg-modified comet assay in kidney cells of ochratoxin A-and fumonisin B1- treated rats.2006;222:53-9.
DOI: https://doi.org/10.2478/10004-1254-60-2009-1938 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian
Page range: 387 - 393
Published on: Jan 7, 2010
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2010 Ana-Marija Domijan, Maja Peraica, Ksenija Markov, Radovan Fuchs, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.